LACOMBE; PATRICK

Patent Applications and Registrations

Patent applications and USPTO patent grants for LACOMBE; PATRICK.The latest application filed is for "small molecule modulators of pcsk9 and methods of use thereof".

Company Profile

0.14.23

LACOMBE; PATRICK - MONTREAL CA
Lacombe; Patrick - Bobigny FR
Lacombe; Patrick - Bobigny Cedex FR
Lacombe; Patrick - Rahway NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Small Molecule Modulators Of Pcsk9 And Methods Of Use Thereof App 20160031935 - GUAY; DANIEL ; et al.	2016-02-04
3,4-substituted piperidine derivatives as renin inhibitors Grant 8,889,714 - Chen , et al. November 18, 2	2014-11-18
Renin inhibitors Grant 8,334,308 - Juteau , et al. December 18, 2	2012-12-18
Renin Inhibitors App 20120046293 - BAYLY; CHRISTOPHER I. ; et al.	2012-02-23
Renin Inhibitors App 20120035214 - McKay; Daniel J. ; et al.	2012-02-09
Renin inhibitors Grant 8,063,105 - Bayly , et al. November 22, 2	2011-11-22
Renin Inhibitors App 20110263658 - Juteau; Helene ; et al.	2011-10-27
Renin Inhibitors App 20110237622 - Chen; Austin Chih-Yu ; et al.	2011-09-29
3,4-substituted Piperidine Derivatives As Renin Inhibitors App 20110152316 - Chen; Austin Chih-Yu ; et al.	2011-06-23
3,4-substituted Piperidine Derivatives As Renin Inhibitors App 20110053940 - Chen; Austin Chih-Yu ; et al.	2011-03-03
Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors Grant 7,622,501 - Dufresne , et al. November 24, 2	2009-11-24
Renin Inhibitors App 20090281103 - Bayly; Christopher I. ; et al.	2009-11-12
8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors Grant 7,482,456 - Dube , et al. January 27, 2	2009-01-27
Combination Therapy for Treating Cyclooxygenase-2 Mediated Diseases or Conditions in Patients at Risk of Thrombotic Cardiovascular Events App 20080242722 - Dufresne; Claude ; et al.	2008-10-02
Nitric Oxide Releasing Prodrugs of Diaryl-2-(5H)-Furanones as Cyclooxygenase-2 Inhibitors App 20080242643 - Dufresne; Claude ; et al.	2008-10-02
4-Oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitor and a method of preparing same App 20080070940 - Dube; Daniel ; et al.	2008-03-20
4-Oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors Grant 7,342,024 - Dube , et al. March 11, 2	2008-03-11
Method of control of light beams emitted by a lighting apparatus of a vehicle and a system for performing this method Grant 7,280,901 - Dubrovin , et al. October 9, 2	2007-10-09
4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors Grant 7,238,706 - Dube , et al. July 3, 2	2007-07-03
4-oxo-1-(3-substituted phenyl)-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitor and a method of preparing same App 20070099951 - Dube; Daniel ; et al.	2007-05-03
8-(biaryl)quinoline PDE4 inhibitors Grant 7,153,968 - Dube , et al. December 26, 2	2006-12-26
Hetero-bridge substituted 8-arylquinoline pde4 inhibitors Grant 7,144,896 - Gallant , et al. December 5, 2	2006-12-05
8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors App 20060223850 - Dube; Daniel ; et al.	2006-10-05
4-Oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors App 20060058316 - Dube; Daniel ; et al.	2006-03-16
Use of phosphodiesterase-4 inhibitors as enhancers of cognition App 20060040981 - Dube; Daniel ; et al.	2006-02-23
Lighting or indicating light unit for a vehicle and lighting or indicating system equipped with at least one such light unit Grant 6,982,648 - Cros , et al. January 3, 2	2006-01-03
Hetero-bridge substituted 8-arylquinoline pde4 inhibitors App 20050245513 - Gallant, Michel ; et al.	2005-11-03
8-(Biaryl)quinoline pde4 inhibitors App 20050234238 - Dube, Daniel ; et al.	2005-10-20
Substituted 8-arylquinolune PDE4 inhibitors Grant 6,919,353 - Dube , et al. July 19, 2	2005-07-19
4-Oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors App 20050107402 - Dube, Daniel ; et al.	2005-05-19
Substituted 8-arylquinolune pde4 inhibitors App 20040162314 - Dube, Daniel ; et al.	2004-08-19
Method of control of light beams emitted by a lighting apparatus of a vehicle and a system for performing this method App 20040085201 - Dubrovin, Alex ; et al.	2004-05-06
Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore Grant 6,627,656 - Gallant , et al. September 30, 2	2003-09-30
Lighting or indicating light unit for a vehicle and lighting or indicating system equipped with at least one such light unit App 20030067220 - Cros, Christophe ; et al.	2003-04-10
Substituted 8-arylquinoline phosphodiesterase-4 inhibitors App 20020103226 - Deschenes, Denis ; et al.	2002-08-01
Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore App 20020082266 - Gallant, Michel ; et al.	2002-06-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.